Literature DB >> 8942516

Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications.

R B Ness1, J M Roberts.   

Abstract

The cause of preeclampsia remains elusive in spite of many attempts to understand its biologic characteristics and to characterize its predictors. We suggest that there are distinct origins of preeclampsia, each with its own pathologic characteristics and natural history. One genesis is the result of reduced placental perfusion, which we will call placental, and another results from maternal disorders preexisting (but sometimes not evident before) pregnancy. These preexisting maternal disorders comprise predisposing factors for cardiovascular disease such as hypertension, renal disease, overweight, and diabetes. A critical review of the epidemiologic and pathologic literature is presented, which supports the hypothesis that preeclampsia is the result of heterogeneous causes. The implications of this hypothesis are discussed, particularly its impact on the development of rules to predict the occurrence of preeclampsia.

Entities:  

Mesh:

Year:  1996        PMID: 8942516     DOI: 10.1016/s0002-9378(96)70056-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  94 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families.

Authors:  Hannele Laivuori; Päivi Lahermo; Vesa Ollikainen; Elisabeth Widen; Leena Häivä-Mällinen; Helena Sundström; Tarja Laitinen; Risto Kaaja; Olavi Ylikorkala; Juha Kere
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

3.  High-resolution imaging diagnosis of human fetal membrane by three-dimensional optical coherence tomography.

Authors:  Hugang Ren; Cecilia Avila; Cynthia Kaplan; Yingtian Pan
Journal:  J Biomed Opt       Date:  2011-11       Impact factor: 3.170

4.  Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?

Authors:  Robert W Powers; James M Roberts; Daniel A Plymire; Dominick Pucci; Saul A Datwyler; Don M Laird; David C Sogin; Arun Jeyabalan; Carl A Hubel; Robin E Gandley
Journal:  Hypertension       Date:  2012-05-29       Impact factor: 10.190

5.  Preeclampsia and Sleep-Disordered Breathing: A Case-Control Study.

Authors:  Francesca L Facco; Justin Lappen; Courtney Lim; Phyllis C Zee; William A Grobman
Journal:  Pregnancy Hypertens       Date:  2013-04       Impact factor: 2.899

6.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

7.  Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality.

Authors:  Cande V Ananth; Olga Basso
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

Review 8.  Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.

Authors:  Virginia D Winn; Matthew Gormley; Agnes C Paquet; Kasper Kjaer-Sorensen; Anita Kramer; Kristen K Rumer; Ronit Haimov-Kochman; Ru-Fang Yeh; Michael T Overgaard; Ajit Varki; Claus Oxvig; Susan J Fisher
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

Review 9.  Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia.

Authors:  Alejandra Perez-Sepulveda; Pedro P España-Perrot; Errol R Norwitz; Sebastián E Illanes
Journal:  Reprod Sci       Date:  2013-03-01       Impact factor: 3.060

10.  Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.

Authors:  Y Yu; K F Hanssen; V Kalyanaraman; A Chirindel; A J Jenkins; A J Nankervis; P A Torjesen; H Scholz; T Henriksen; B Lorentzen; S K Garg; M K Menard; S M Hammad; J A Scardo; J R Stanley; M Wu; A Basu; C E Aston; T J Lyons
Journal:  BJOG       Date:  2012-08-20       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.